# Clinical Validation of a Raman Spectroscope to Determine Hepatic Fat Content

> **NCT02621853** · NA · TERMINATED · sponsor: **Nova Scotia Health Authority** · enrollment: 3 (actual)

## Conditions studied

- Steatosis

## Interventions

- **DEVICE:** Raman spectroscopy of the liver

## Key facts

- **NCT ID:** NCT02621853
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12-15
- **Primary completion:** 2016-03-10
- **Final completion:** 2017-03-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Principal Investigator is also study sponsor. Dr. Alwayn is leaving NSHA and Canada for a new appointment in Europe.
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621853, "Clinical Validation of a Raman Spectroscope to Determine Hepatic Fat Content". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02621853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*